Omics-based identification of pathophysiological processes.

Hiroshi Tanaka, Soichi Ogishima

Research output: Contribution to journalArticlepeer-review

3 Citations (Scopus)

Abstract

Owing to the growing knowledge about the cellular molecular network and its alterations in diseases, most of the diseases become considered as "systems distortion of the cellular molecular network". This view of diseases, which we call "systems pathology", has brought about a new usage of the disease Omics, that is, to identify the altered molecular network underlying the disease. In this chapter, we discuss the technologies and clinical applications for Omics-based identification of pathophysiological process. In doing so, we classify the methods into two classes: one is a "data-inductive approach" which infers gene regulatory and transcriptional networks by gene expression data from DNA microarrays, and the other is a "knowledge-referenced approach" which combines the differentially expressed genes from gene expression profiles with existing protein interaction networks or literature-curated pathways. Several typical methods such as ARACNe and eQTL are described with their recent clinical applications.

Original languageEnglish
Pages (from-to)499-509
Number of pages11
JournalMethods in molecular biology (Clifton, N.J.)
Volume719
DOIs
Publication statusPublished - 2011

ASJC Scopus subject areas

  • Molecular Biology
  • Genetics

Fingerprint Dive into the research topics of 'Omics-based identification of pathophysiological processes.'. Together they form a unique fingerprint.

Cite this